Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism RSV F protein agonists(Respiratory syncytial virus F protein agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Syncytial Virus Infections | Preclinical | - | 12 Jun 2024 |